Add-on Seminars
Add-on Seminars are scheduled for the day before and the
day
following the main Annual Meeting programming. The following
additional fees apply:
Half Day Seminar - $150.00
Full Day Seminar - $ 250.00
Add-on Seminar 1
Add-on Seminar 2
Add-on Seminar 3
Add-on Seminar 4
Add-on Seminar 5 - Moved to Workshop 5-VAL-6
Add-on Seminar 6
Add-on Seminar 7
| SUNDAY, OCTOBER 19 |
| Sunday Add-on Seminars include: |
| 8:00 a.m. - 8:30 a.m. |
Continental Breakfast |
| 10:00 a.m. - 10:30 a.m. |
Networking Coffee Break |
| 12:00 p.m. - 1:00 p.m. |
Luncheon for Full Day Add-on Attendees |
| 3:00 p.m. - 3:30 p.m. |
Networking Coffee Break |
ADD-ON SEMINAR 1 · 8:30 a.m. - 5:00 p.m.
Anatomy of Deals in the News: 3rd Annual Practical
Tutorial for Licensing Road Warriors
 Health Care Sector
You will not want to miss this unique LES Healthcare Add-On, where you have the opportunity to spend the day analyzing four diverse deals with the deal makers. But be prepared... this will be an interactive session where you work in break-out groups, where you will be tasked with addressing the key issues faced by our deal makers. Imagine the value of applying the learnings from such deals directly into your own transactions! Find out what the key issues were and what took these deals to the finish line.
1. Shire & Amicus—Gain insight into their multi-product collaboration valued up to $440M, plus royalties and cost sharing for development toward approval. Shire gains ex-U.S. rights while Amicus retains U.S. commercial rights.
2.Genentech & Seattle Genetics—Gain an understanding of what rekindled Genentech'
s interest in SGN-40—an hMAB in P-I and P-2 for MM, CLL, and NHL. Deal terms include $60M upfront payment to Seattle Genetics, with potential milestones >$800M and escalating double-digit royalties
3. Merck & GTx—Join us in exploring Merck'
s agreement with an emerging biotech company, GTx for a broad strategic collaboration for selective androgen receptor modulators (SARMs), a new class of drugs with the potential to treat age-related muscle loss (sarcopenia), as well as other musculoskeletal conditions.
4. Cyclacel Pharmaceuticals & Align Pharmaceuticals—Gain an understanding of how Cyclacel was able to acquire Align Pharmaceuticals with marketed oncology products to complement Cyclacel'
s innovative oncology pipeline.
Chair: Ruth A Plager, President, ZenithBIO LLC
Facilitators:
Michael J. Lerner, Partner, Lowenstein, Sandler PC
Jerry Middleton, Vice President, Corporate Development, Elusys
Mark Nawacki, Vice President, Business Development, Paladin Labs Inc.
Deal Presenters:
Hugh Cole, Vice President, Business Development, Shire, Human Genetic Therapies
Bradley Campbell, Vice President, Business Planning, Amicus Therapeutics
Eric Dobmeier, Chief Business Officer, Seattle Genetics
Marc Hanover, President & Chief Operating Officer, GTx
Kinney Horn, Senior Manager, Business Development, Genentech
Sunil Patel, Senior Director, Corporate Licensing, Merck & Co.
John Womelsdorf, Ph.D., Vice President, Business Development, Cyclacel
ADD-ON SEMINAR 2 · 8:30 a.m. - 5:00 p.m.
Marketing Inventions: Leveraging Resources in a Small Office
 Industry-University-Government Interface Sector
One of the toughest challenges facing most technology transfer professionals is the marketing of inventions, especially with limited resources and experience. Most tech transfer professionals have little or no marketing background or experience. Most tech transfer organizations deal with inventions at the earliest stage, where there is not an identifiable product. This workshop will help the TTO to understand how to: identify opportunities for licensing, describe the invention to attract licensees, expand contacts to create licensing opportunities, and how to use limited resources to accomplish all of the above. Experts will share their marketing tips, successes, failures, and best ideas.
Moderator: Michael J. Martin, President, TechTransfer Associates, Inc.
Speakers:
Mike Martin, President, TechTransfer Associates, Inc.
Imelda Oropeza, Copyright Licensing &Marketing Specialist, Stanford University
Elaine White, Vice President, Business Development, Foresight Science & Technology, Inc.
ADD-ON SEMINAR 3 · 8:30 a.m. - 5:00 p.m.
Ask the Experts: Valuation, Taxation and Pricing Issues with Intellectual Property
Sponsored by the Valuation & Taxation Committee
Everything you always wanted to know, but didn't know who to ask about valuation, taxation and pricing of intellectual property. Here is your chance to tap into the knowledge and experience of a panel of consulting experts who will address varied financial and business topics of importance to IP professionals. Panelists will begin with a presentation of hot topics in IP valuation, including informative case examples, followed by an extended Q&A with participants. Topics on tap for this interactive full day add-on may include valuation and pricing of early stage technologies, analysis of risk in valuation, Monte Carlo analysis, real options, auctions, damages, or other topics of interest to attendees.
Robert Goldman, Principal, CRA International
Kathleen Kedrowski, Managing Director, Navigant Consulting
Michael Lasinski, Managing Director, Ocean Tomo
Mohan Rao, Director, LECG, LLC
ADD-ON SEMINAR 4 ·1:00 p.m. - 5:00 p.m.
Silicon Valley Strategies For Successful Licensing – What the Experts in Silicon Valley Are Doing
 High Technology Sector
An in-depth look at what industry, universities, research labs and brokers are doing in Silicon Valley to commercialize technology in light of the new challenges facing patent owners. This specially chosen panel will provide examples of a broad vision of how and why licensing, under the right circumstances and management, are working in various aspects of industry, university and government. Hear the experts provide what they are doing and the requirements for preparation to lead to successful negotiations. It takes much more than technology to achieve the licensing objectives for mutual benefits. Hear what the experts are doing in Silicon Valley to meet the challenges of the antipatent decisions of MedImmune and Sandisk.
Moderator: Larry Udell, Co-Chair, LES Silicon Valley Chapter, Managing Director, Intellectual Property International, Ltd.
Speakers:
Linda Chao, Senior Associate, Stanford University
Mark Holmes, Co-Chair, LES Silicon Valley Chapter, Chief Executive Officer, PatentBridge LLC
Damon Matteo, Vice President & Chief Intellectual Property Officer, Palo Alto Research Center (PARC)
Craig Smith, Technology Licensing Manager, Sandia National Laboratories
Christopher Talbot, Senior Director Licensing, Applied Materials
ADD-ON SEMINAR 5 · 1:00 p.m. - 5:00 p.m.
Revenue Interest Financing
 Financial Markets Committee
Moved to Workshop 5-VAL-6
ADD-ON SEMINAR 6 · 8:00 a.m. - 6:00 p.m.
Exploring NASA: Licensing Opportunities with the U.S. Government
Co-Sponsored by: High Technology Sector and Industry-University- Government Interface Sectors
Open to registrants, Accompanying Persons & Children
Enjoy a day at Kennedy Space Center with your family! This Add-on is open to meeting attendees and accompanying persons and children. Upon arriving at Kennedy Space Center, Add-on Seminar attendees will attend a three-hour educational session which features speakers from the LES High Technology, Health Care, and IUGI Sectors to discuss key aspects of licensing with the U.S. Government. While attendees are in the morning seminar, Accompanying Persons and children are free to explore Live Programs, Shows, Exhibits, IMAX Films, and the Astronaut Hall of Fame.
Seminar attendees and Accompanying Persons join each other to "
Dine with an Astronaut,"
an amazing opportunity that includes an appearance from an astronaut who will share space experiences and answer questions from the audience. Following lunch, participants will embark on a guided Kennedy Space Center Tour, including views of the Space Center, Space Shuttle launch pads, rocket launch pads at Cape Canaveral Air Force Station, and more.
Moderator:
Lori Morrisson, Licensing Manager, Northrop Grumman Corp.
Julia Bowen, Associate General Counsel, The MITRE Corporation
Michael Muthig, Project Manager, Current Technologies Corporation
John Yadvish, Deputy Director, Innovative Partnerships Program Office, NASA Goddard Space Flight Center
ADD-ON SEMINAR 7 · 8:00 a.m. - 5:00 p.m.
One-Day Introductory Workshop on the Commercialization of Intellectual Property through Licensing
Sponsored by LESI Education Committee
- Are you interested in understanding how to create or use intellectual property?
- Are you either a potential licensor or a licensee?
- Do you want to develop expertise in the field of intellectual asset development and management and in the field of licensing?
- Do you want to refresh your understanding of IP and licensing?
If you answer Yes to any of these questions, then you are a candidate for this one-day course. Taught by experienced LES faculty, this program will highlight the key topics and concepts used in today'
s increasingly complex licensing transactions.
Fee: $195.00
Instructors:
Brad DeSandro, Patent Attorney, Quarles & Brady LLP
Paul Germeraad, President, Intellectual Assets, Inc.
Mark Peterson, Chief Executive Officer, Robinwood Consulting |
